EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 46 filers reported holding EIDOS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $204,900,000 | +168.6% | 1,557,225 | +3.1% | 0.01% | +133.3% |
| Q3 2020 | $76,291,000 | +8.6% | 1,509,748 | +2.5% | 0.00% | 0.0% |
| Q2 2020 | $70,243,000 | +1.2% | 1,473,515 | +4.0% | 0.00% | 0.0% |
| Q1 2020 | $69,440,000 | -8.6% | 1,417,421 | +7.1% | 0.00% | 0.0% |
| Q4 2019 | $75,966,000 | +58.1% | 1,323,689 | -0.9% | 0.00% | +50.0% |
| Q3 2019 | $48,038,000 | +12.9% | 1,335,527 | -2.5% | 0.00% | 0.0% |
| Q2 2019 | $42,558,000 | +12.5% | 1,369,356 | -15.1% | 0.00% | 0.0% |
| Q1 2019 | $37,842,000 | +139.3% | 1,613,751 | +40.4% | 0.00% | +100.0% |
| Q4 2018 | $15,814,000 | +117.7% | 1,149,364 | +57.9% | 0.00% | – |
| Q3 2018 | $7,264,000 | +138.1% | 727,698 | +385.1% | 0.00% | – |
| Q2 2018 | $3,051,000 | – | 150,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
| Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
| RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
| Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
| Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
| Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
| Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
| Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
| Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |